Avidity Biosciences Inc
(RNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -139,648 | -68,855 | -212,220 | -151,777 | -99,419 |
| Depreciation Amortization | -6,107 | -2,319 | -9,173 | -6,551 | -4,151 |
| Other Working Capital | -14,399 | -10,340 | 61,129 | -7,768 | -15,181 |
| Other Operating Activity | 24,770 | 11,134 | 41,200 | 30,531 | 19,977 |
| Operating Cash Flow | $-135,384 | $-70,380 | $-119,064 | $-135,565 | $-98,774 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -306,170 | -31,832 | -125,842 | -177,745 | -147,189 |
| PPE Investments | -1,446 | -915 | -4,228 | -3,365 | -2,442 |
| Investing Cash Flow | $-307,616 | $-32,747 | $-130,070 | $-181,110 | $-149,631 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 456,386 | 389,445 | 93,864 | 61,973 | 61,933 |
| Other Financing Activity | 379,783 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $836,169 | $389,445 | $93,864 | $61,973 | $61,933 |
| Beginning Cash Position | 185,377 | 185,377 | 340,647 | 340,647 | 340,647 |
| End Cash Position | 578,546 | 471,695 | 185,377 | 85,945 | 154,175 |
| Net Cash Flow | $393,169 | $286,318 | $-155,270 | $-254,702 | $-186,472 |
| Free Cash Flow | |||||
| Operating Cash Flow | -135,384 | -70,380 | -119,064 | -135,565 | -98,774 |
| Capital Expenditure | -1,446 | -915 | -4,228 | -3,365 | -2,442 |
| Free Cash Flow | -136,830 | -71,295 | -123,292 | -138,930 | -101,216 |